채용
About This Role
Biogen is seeking an experienced Business Development Counsel with deep expertise in Biotechnology and pharmaceutical licensing and strategic collaborations to join its legal team. Reporting to the Chief Corporate Counsel, this role is based at Biogen’s headquarters in Cambridge, MA and serves as a critical legal partner to the company’s global business development organization. In this role, you will lead legal support for in‑licensing, out‑licensing, co‑development, collaboration, and other strategic alliance transactions that are central to Biogen’s pipeline growth and long‑term innovation strategy. You will play a hands‑on role in shaping deal strategy, structuring complex partnership models, and guiding transactions from early evaluation through execution and lifecycle management. Your work will directly influence Biogen’s ability to access external innovation and build high‑value partnerships across the biotechnology and pharmaceutical ecosystem.
What You’ll Do
- Lead legal diligence and structuring for pharmaceutical licensing, collaboration, and strategic partnership transactions, advising on deal architecture, value drivers, and risk allocation.
- Draft, review, and negotiate term sheets and definitive agreements, including license agreements, collaboration and co‑development agreements, option deals, alliance agreements, and related ancillary contracts.
- Serve as the primary legal advisor on business development transactions, supporting deal teams from initial evaluation through negotiation, execution, and post‑signing governance.
- Partner closely with Business Development, R&D, IP, Commercial, Finance, and Tax stakeholders to align transaction terms with scientific strategy, development plans, and commercialization objectives.
- Collaborate with IP counsel on intellectual property, exclusivity, improvements, and freedom‑to‑operate issues central to pharmaceutical licensing deals.
- Support internal governance processes, ensuring transactions align with Biogen’s strategic priorities, risk tolerance, and internal approval frameworks.
- Manage and oversee outside counsel on complex licensing and collaboration matters, ensuring efficiency, quality, and cost‑effective execution.
- Provide ongoing legal advice to internal teams on alliance management, contract interpretation, amendments, and dispute mitigation over the life of partnerships.
- Ensure compliance with all applicable laws, regulations, and internal policies governing strategic collaborations and licensing activity.
Who You Are
You are a seasoned legal advisor with a strong reputation for excellence in pharmaceutical and biotechnology partnering transactions. You combine sound legal judgment with commercial insight and excel at navigating the intersection of science, business strategy, and risk management. You are comfortable working on complex, high‑value deals and are viewed by stakeholders as a trusted collaborator who enables innovation while safeguarding the company’s interests. You bring gravitas, clarity, and pragmatism to negotiations and thrive in a fast‑moving, matrixed environment.
Required Skills
- Minimum of 12 years’ experience in a leading law firm and/or in‑house legal department, with significant focus on life sciences transactions.
- Demonstrated expertise in biotechnology and pharmaceutical licensing, strategic collaborations, co‑development agreements, and alliance structures; M&A and venture experience a plus.
- Juris Doctor (JD) degree with active bar licensure.
- Strong ability to translate complex legal concepts into practical business advice for senior stakeholders.
- Proven judgment, negotiation skills, and executive‑level communication capabilities.
- Experience establishing effective legal processes and managing risk in high‑impact transactional environments.
Job Level: Management
Additional Information
The base compensation range for this role is: $226,000.00-$311,000.00
Base salary offered is determined through an analytical approach utilizing a combination of factors including, but not limited to, relevant skills & experience, job location, and internal equity.
Regular employees are eligible to receive both short term and long-term incentives, including cash bonus and equity incentive opportunities, designed to reward recent achievements and recognize your future potential based on individual, business unit and company performance.
In addition to compensation, Biogen offers a full and highly competitive range of benefits designed to support our employees’ and their families physical, financial, emotional, and social well-being; including, but not limited to:
- Medical, Dental, Vision, & Life insurances
- Fitness & Wellness programs including a fitness reimbursement
- Short- and Long-Term Disability insurance
- A minimum of 15 days of paid vacation and an additional end-of-year shutdown time off (Dec 26-Dec 31)
- Up to 12 company paid holidays + 3 paid days off for Personal Significance
- 80 hours of sick time per calendar year
- Paid Maternity and Parental Leave benefit
- 401(k) program participation with company matched contributions
- Employee stock purchase plan
- Tuition reimbursement of up to $10,000 per calendar year
- Employee Resource Groups participation
Why Biogen?
We are a global team with a commitment to excellence, and a pioneering spirit. As a mid-sized biotechnology company, we provide the stability and resources of a well-established business while fostering an environment where individual contributions make a significant impact. Our team encompasses some of the most talented and passionate achievers who have unparalleled opportunities for learning, growth, and expanding their skills. Above all, we work together to deliver life-changing medicines, with every role playing a vital part in our mission. Caring Deeply. Achieving Excellence. Changing Lives.
At Biogen, we are committed to building on our culture of inclusion and belonging that reflects the communities where we operate and the patients we serve. We know that diverse backgrounds, cultures, and perspectives make us a stronger and more innovative company, and we are focused on building teams where every employee feels empowered and inspired. Read on to learn more about our DE&I efforts.
All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.
총 조회수
0
총 지원 클릭 수
0
모의 지원자 수
0
스크랩
0
비슷한 채용공고

Business Systems Analyst
Leidos · Atlanta, GA

Global Banking Intelligence & Growth Strategy
JPMorgan Chase · New York, NY, United States, US

Business Development Representative (BDR)
Sherwin-Williams · King of Prussia, PA, United States, US

Marketplace Strategic Partnerships Developer
Best Buy · Richfield, Minnesota, United States

District Partnership Specialist, California - Central Coast
IXL Learning · Remote
Biogen 소개

Biogen
PublicSpecializing in the treatment of neurological diseases.
5,001-10,000
직원 수
Cambridge
본사 위치
$16.2B
기업 가치
리뷰
4.1
10개 리뷰
워라밸
3.8
보상
4.2
문화
4.5
커리어
3.5
경영진
4.0
78%
친구에게 추천
장점
Supportive management and team culture
Excellent health benefits and competitive compensation
Flexible working hours and remote options
단점
Heavy workload and long hours during deadlines
High-pressure environment leading to stress and burnout
Limited growth potential in some departments
연봉 정보
547개 데이터
Junior/L3
Senior/L5
Junior/L3 · Business Analyst
1개 리포트
$93,408
총 연봉
기본급
$81,224
주식
-
보너스
-
$93,408
$93,408
면접 경험
47개 면접
난이도
3.5
/ 5
소요 기간
14-28주
합격률
36%
경험
긍정 65%
보통 25%
부정 10%
면접 과정
1
Phone Screen
2
Technical Interview
3
System Design
4
Behavioral
5
Team Fit
자주 나오는 질문
Tell me about a challenging project
System design question
Coding problem
Why this company
뉴스 & 버즈
Goldman Sachs Adjusts Price Target on Biogen to $238 From $231, Maintains Buy Rating - marketscreener.com
marketscreener.com
News
·
1d ago
Jim Cramer Says “I Got to Reopen the File on Biogen” - Yahoo Finance
Yahoo Finance
News
·
2d ago
Biogen expands control of CD38 antibody felzartamab across global markets - Drug Discovery News
Drug Discovery News
News
·
3d ago
Biogen bullish on America with Durham Bulls team up - Fierce Pharma
Fierce Pharma
News
·
5d ago